Business Context and Reporting Period
This Form 8-K Current Report was filed by Zimmer Biomet Holdings, Inc. on May 16, 2022. The filing primarily addresses the appointment of a new senior executive officer and the associated compensatory arrangements.
Key Financial Metrics
This filing does not contain financial performance data such as revenue, profit, cash flow, margins, debt, or liquidity metrics. The document focuses exclusively on executive compensation details.
- Base Salary: $375,000 annualized for the new appointee.
- Target Bonus: 60% of base salary (prorated for 2022).
- Sign-on Bonus: $100,000 cash.
- Long-Term Incentive (2023): Grant date fair value of approximately $400,000.
- Sign-on Equity Award: Grant date fair value of approximately $440,000 (50% stock options, 50% RSUs).
Material Changes
The material change reported is the appointment of Paul Stellato as Vice President, Controller, and Chief Accounting Officer, effective May 16, 2022. He replaces Derek Davis, who served as Interim Controller and Chief Accounting Officer. Mr. Davis will continue in his role as Vice President, Finance Integration.
Guidance, Outlook, and Risks
The filing contains no financial guidance, outlook, or management commentary regarding future business performance. Key contingencies and risks related to the appointment include:
- Clawback Provision: The $100,000 sign-on bonus must be repaid if Mr. Stellato voluntarily leaves or is terminated for cause within two years.
- Equity Vesting: The sign-on equity award vests ratably over three years starting June 1, 2022, subject to continued employment.
- Restrictive Covenants: Mr. Stellato entered into a Confidentiality, Non-Competition, and Non-Solicitation Agreement as a condition of receiving equity awards.
- Severance: The appointment includes severance benefits for change in control and involuntary termination without cause, referencing existing company plans.
Investor Verification Checklist
- Verify the full text of the Offer Letter (Exhibit 10.1) for specific performance goals tied to the annual incentive.
- Review the Change in Control Severance Agreement (Exhibit 10.2) and Executive Severance Plan (Exhibit 10.3) to understand potential payout scenarios.
- Confirm the vesting schedule and grant date details for the sign-on equity award in the 2009 Stock Incentive Plan.
- Check the Non-Competition Agreement (Exhibit 10.4) for specific restrictions on future employment.